← Back to The Daily Signal
Large green leaves on a kratom tree

Mitragyna speciosa: the leaf is not the target. Concentrated 7-OH products are.

ThorPorreCC BY 3.0

The plant itself. The DEA proposal targets concentrated 7-OH products, not the leaf as such.

Supplements & Nootropics

The DEA Just Drew a Number Around Kratom's Strongest Compound

Kratom has spent years in a gray zone: a leaf sold as a supplement, a powder sold as a tea, and lately concentrated pills and shots built around one of its most potent compounds. In October the DEA put a number on where the gray zone ends.

Written by Sama Alabed · November 19, 2026

The short version

What the notice says

The notice, document 2026-20943 in the Federal Register, follows a letter from HHS dated October 8. It proposes a temporary scheduling order covering 7-hydroxymitragynine, known as 7-OH, and mitragynine pseudoindoxyl, known as MP. A product would fall into Schedule I, the most restricted category, if the two compounds alone or combined exceed 1 mg per gram for solids or 1 mg per milliliter for liquids.

The threshold is an enforcement line, not a safety rating.

There is a second trigger. A product would also be covered if the mass of mitragynine, the main alkaloid in the kratom leaf, is less than 100 times the mass of 7-OH and MP. In practice that targets products where 7-OH has been concentrated far beyond its share in the leaf, even if the per gram amount is small.

What changed since summer

The DEA is withdrawing a notice it published on July 6, 2026, which used a lower threshold. A separate order from August 26 placed MP and two related compounds, MGM-15 and MGM-16, in Schedule I with no threshold at all. That order stays in effect until it expires or until the new temporary order is published and the old one is withdrawn.

The new order can be published no sooner than 30 days after the notice, which put the earliest date in mid November. We did not find confirmation that it has been published.

The sentence worth reading twice

The notice states that neither HHS nor DEA has made a finding that these substances are safe to use at below threshold levels. The threshold is an enforcement line, not a safety rating. A product that stays legal under it has not been declared safe.

Honest caveat

This is a notice of intent for a temporary order, not a final rule. Temporary scheduling orders are time limited, and the details can change in the final order. We did not confirm whether the final order was published by November 19, 2026. Nothing here assesses whether kratom leaf products are safe or effective.

What this means for you

If you use kratom, the products most likely to be affected are concentrated 7-OH pills, shots and tablets rather than plain leaf powder. Labels that list 7-OH as a headline ingredient are the clearest sign of a product built around the compound this order targets.

Whatever the legal line ends up being, 7-OH is a potent opioid receptor agonist, and dependence and withdrawal are real risks. If you are trying to cut back, a clinician can help, and stopping suddenly after heavy use is worth planning rather than improvising.

Primary sources

  1. DEA, notice of intent to temporarily schedule 7-hydroxymitragynine and mitragynine pseudoindoxyl above a threshold, FR Doc. 2026-20943, Docket DEA-1570, published October 14, 2026

Common questions

Is kratom being banned?

Not all kratom. The proposal targets products with more than 1 mg of 7-OH or mitragynine pseudoindoxyl per gram or milliliter, or with a mitragynine to 7-OH ratio below 100. It is a notice of intent for a temporary order.

Does a product under the threshold count as safe?

No. The notice states that neither HHS nor DEA has found these substances safe at below threshold levels.

What happened to the July proposal?

The DEA is withdrawing its July 6, 2026 notice, which used a lower threshold, and replacing it with this one. An August order covering MP and two related compounds without any threshold stays in effect until the new order replaces it or it expires.

Continue readingSupplements & NootropicsAustralia Banned a Cold and Flu Herb. The Pushback Makes the More Useful Point.Days after Australia's TGA pulled Andrographis paniculata over 287 anaphylaxis reports, industry bodies and an independent researcher pointed out the TGA never converted those reports into a rate, and skipped a front of pack warning as a middle option. A survey found about 35 percent of users would buy the herb from overseas websites instead, where 23 of 26 scanned products carried no allergy warning at all and a peer reviewed lab found some contaminated with mercury and strychnine.Read the story
Kratom7-OHDEARegulationSupplements

#Kratom#7OH#DEA#SupplementRegulation#Supplements

Stay Curious.

Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.